tauriga sciences inc (TAUG:OTC US)

Executive Profile*

Background*

Dr. Laurence Terrisse Rulleau, Ph.D. served as an Analyst of Desjardins Securities at Desjardins Financial Corp. Dr. Rulleau served as Research Analyst of Desjardins Securities Inc., Research Division, Stonecap Securities Inc., Research Division, Macquarie Capital Markets Canada Ltd., Research Division and Macquarie Research. She was Investment Banking Professional at Macquarie Capital Markets Canada Ltd. she has over ten years of experience as a sell-side biotech analyst ... covering the healthcare sector. In her experience as an analyst, she researched over 100 life sciences companies and was ranked the number one Canadian analyst by the Starmine survey (a Thomson Reuters Company). Dr. Rulleau was involved in numerous transactions to help put in place strategic and financing plans. She worked for Blackmont Capital, Orion Securities, Desjardins Securities and Laurentian Bank. She has been a Member of Business Advisory Board at Immunovative, Inc. since August 2012. She has been a Member of the Scientific Advisory Board at Immunovative Therapies Ltd. since September 2012. She is the author of numerous scientific papers in peer review journals and presented at worldwide scientific conventions. Dr. Rulleau has a Masters in Biology from The Universite du Quebec a Montreal (UQAM) and a Ph.D. from Montreal Clinical Research Institute.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
TAUG:US	$0.05 USD	-0.0068

COMPETITOR COMPENSATION